| Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. |
2023-09-18 |
| Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. |
2023-09-12 |
| Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. |
2023-09-11 |
| Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. |
2023-09-06 |
| Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. |
2023-09-05 |
| BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". |
2023-09-04 |
| CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. |
2023-08-29 |
| Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". |
2023-08-21 |
| Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". |
2023-08-21 |
| BioLamina AB. (8/16/23). "Press Release: BioLamina Announces Appointment of New Management Team Members". |
2023-08-16 |
| Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. |
2023-08-10 |
| Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. |
2023-08-08 |
| IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. |
2023-08-07 |
| Bico Group AB. (8/3/23). "Press Release: Bico Divests Berlin Property for a Total of EUR 21m". |
2023-08-03 |
| Biovian Oy. (7/26/23). "Press Release: Biovian Announces over €50 Million Investment in Manufacturing Facility in Turku, Finland". |
2023-07-26 |
| Golgi Neurosciences S.r.l.. (7/25/23). "Press Release: Golgi Neurosciences and Breye Therapeutics Announce Successful Closing of P2X7 Receptor Antagonist program transfer". Milan & Copenhagen. |
2023-07-25 |
| Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. |
2023-07-19 |
| High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. |
2023-07-14 |
| BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. |
2023-07-13 |
| Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. |
2023-07-05 |
| NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. |
2023-07-03 |
| EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. |
2023-06-27 |
| EQT AB. (6/21/23). "Press Release: EQT Private Equity to Sell Ellab, Following Transformation into a Leading Validation & Monitoring Provider for the Biotech and Pharmaceutical Industries". |
2023-06-21 |
| Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich. |
2023-06-20 |
| Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. |
2023-06-13 |
| BC Platforms AG. (6/1/23). "Press Release: BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data". Zurich. |
2023-06-01 |
| IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY. |
2023-06-01 |
| VarmX B.V.. (5/25/23). "Press Release: VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial". Leiden. |
2023-05-25 |
| ElevateBio, LLC. (5/24/23). "Press Release: ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth". Waltham, MA. |
2023-05-24 |
| Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. |
2023-05-17 |
| Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen. |
2023-05-09 |
| Neogap Therapeutics AB. (5/4/23). "Press Release: Neogap and Cellerys Enter Collaboration Related to Phase II Study of a New Therapy for Multiple Sclerosis". |
2023-05-04 |
| va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen. |
2023-04-26 |
| EniferBio Ltd.. (4/19/23). "Press Release: EniferBio raises €11M to Make Planet-friendly Fungal Protein from the By-products of food and agricultural processes". Espoo. |
2023-04-19 |
| Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. |
2023-04-17 |
| Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. |
2023-04-17 |
| Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. |
2023-04-13 |
| Mithra Pharmaceuticals S.A.. (4/4/23). "Press Release: Mithra Announces the Appointment of David H Solomon as Chief Executive Officer". Liège. |
2023-04-04 |
| Capitainer AB. (4/4/23). "Press Release: Capitainer Launches Fully Automated Sample Handler". Stockholm. |
2023-04-04 |
| AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. |
2023-04-04 |
| Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. |
2023-04-04 |
| AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". |
2023-04-03 |
| PolyPeptide Group AG. (4/3/23). "Press Release: PolyPeptide Appoints Juan-José Gonzalez as CEO and Announces Change of CFO". Baar. |
2023-04-03 |
| EQT AB. (3/29/23). "Press Release: EQT Life Sciences Closes Dementia Fund at the Hard Cap". |
2023-03-29 |
| Alligator Bioscience AB. (3/22/23). "Press Release: Alligator Intends to Carry Out a 91 Percent Secured Rights Issue of Units of Approximately SEK 199 Million [Not for US, AU, et al.]". |
2023-03-22 |
| Biovian Oy. (3/16/23). "Press Release: Remedium Bio and Biovian Have Agreed to Collaborate on Remedium’s First-in-Class Disease Modifying AAV Gene Therapy for Osteoarthritis". |
2023-03-16 |
| Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. |
2023-03-14 |
| EQL Pharma AB. (3/13/23). "Press Release: EQL Pharma Recruits Carl Lindgren as Chief Business Development Officer". |
2023-03-13 |
| Oncopeptides AB. (3/8/23). "Press Release: Oncopeptides CSO Investigated for Violation of the Market Abuse Act". |
2023-03-08 |
| Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. |
2023-03-03 |
| Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology". |
2023-02-27 |
| Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. |
2023-02-22 |
| Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA. |
2023-02-21 |
| Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. |
2023-02-16 |
| Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. |
2023-02-15 |
| APK AG. (2/8/23). "Press Release: LyondellBasell and KIRKBI Invest in APK to Develop Recycling technology". Rotterdam, Billund & Merseburg. |
2023-02-08 |
| Novalis Biotech. (2/6/23). "Press Release: Novalis Biotech Invests in Rarity Bioscience’s Ultra Sensitive Genomics Technology". Uppsala. |
2023-02-06 |
| va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. |
2023-01-30 |
| Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. |
2023-01-30 |
| Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. |
2023-01-25 |
| Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director". |
2023-01-24 |
| AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. |
2023-01-24 |
| Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm. |
2023-01-16 |
| TATAA Biocenter AB. (1/11/23). "Press Release: TATAA Biocenter Partners with Universal Sequencing Technology Corporation to Offer “Linked Long Read” Sequencing Services". |
2023-01-11 |
| Oncopeptides AB. (1/11/23). "Press Release: Oncopeptides Appoints Holger Lembrer as Chief Financial Officer". Stockholm. |
2023-01-11 |
| Evosep ApS. (1/9/23). "Press Release: Evosep Receives Strategic Investment from Novo Holdings A/S to Accelerate Its Effort on Clinical Proteomics". Odense. |
2023-01-09 |
| Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. |
2023-01-09 |
| Agilent Technologies Inc.. (1/6/23). "Press Release: Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications". Santa Clara, CA & Marlborough, MA. |
2023-01-06 |
| Bactolife A/S. (1/4/23). "Press Release: Bactolife Appoints Sebastian Søderberg New CEO". Copenhagen. |
2023-01-04 |
| Oncopeptides AB. (1/4/23). "Press Release: Monica Shaw Appointed CEO of Oncopeptides – Jakob Lindberg Assumes Position as Chief Scientific Officer". Stockholm. |
2023-01-04 |
| Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO". |
2023-01-02 |
| Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. |
2022-12-23 |
| European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". |
2022-12-23 |
| ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
| Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. |
2022-12-19 |
| Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
| Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. |
2022-12-12 |
| Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
| Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm. |
2022-12-07 |
| MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". |
2022-11-29 |
| Rarity Bioscience AB. (11/29/22). "Press Release: Rarity Bioscience Raises €2.5M in Seed Funding to Improve Cancer Care". Uppsala. |
2022-11-29 |
| Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. |
2022-11-24 |
| Novo Nordisk A/S. (11/22/22). "Press Release: Novo Nordisk Invests DKK 5.4 bn Danish Kroner in Expansion of Clinical Manufacturing Facilities in Bagsværd, Denmark". Bagsværd. |
2022-11-22 |
| Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
| European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". |
2022-11-18 |
| Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. |
2022-11-11 |
| BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". |
2022-11-08 |
| OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. |
2022-11-07 |
| Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. |
2022-10-31 |
| Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. |
2022-10-24 |
| FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. |
2022-10-20 |
| Hemispherian AS. (10/19/22). "Press Release: Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program". Oslo. |
2022-10-19 |
| Inversago Pharma Inc.. (10/19/22). "Press Release: Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors". Montréal, QC. |
2022-10-19 |
| Inversago Pharma Inc.. (10/17/22). "Press Release: Inversago Pharma Raises $95 Million CAD in Series C Financing". Montréal, QC. |
2022-10-17 |
| Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. |
2022-10-17 |
| Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. |
2022-10-11 |
| Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. |
2022-10-10 |
| IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. |
2022-10-07 |
| Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. |
2022-09-30 |
| Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. |
2022-09-29 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
